Durvalumab vs Memantine

Durvalumab vs Memantine: Overview

This comparison examines the pharmacological differences between Durvalumab and Memantine.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Memantine: Non-competitive NMDA receptor antagonist.

Pharmacokinetics

Half-life: Durvalumab — 17 days; Memantine — 60-80 hours.

Chemical Properties

Molecular Formula: Memantine — C12H21N.

Molecular Weight: Memantine — 179.3080 g/mol.

Type: Durvalumab — Antibody; Memantine — Small molecule.